Klinikum der Stadt Ludwigshafen am Rhein gGmbH

Hospital


Location: Ludwigshafen, Germany (DE) DE

ISNI: 0000000403998793

ROR: https://ror.org/037wq4b75

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Seizure Semiology in Antibody-Associated Autoimmune Encephalitis (2022) Kaaden T, Madlener M, Angstwurm K, Bien CG, Bogarin Y, Doppler K, Finke A, et al. Journal article Risk of pelvic metastasis and significance of pelvic lymphadenectomy in patients with node-positive vulvar cancer - results of the AGO-VOP.2/QS vulva study (2022) Jaeger A, Hampl M, Zu Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution Female Psoriatic Arthritis Patients Show Differences in Treatment Response to IL12/23 Inhibition in Combination with or Without MTX Compared to Male - Results from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial (2022) Koehm M, Foldenauer AC, Rossmanith T, Kellner H, Kiltz U, Rech J, Burmester G, et al. Conference contribution Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG (2022) Franklin C, Mohr P, Meier F, Weichenthal M, Grimmel-Mann I, Gutzmer R, Utikal JS, et al. Conference contribution Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG (2022) Franklin C, Mohr P, Bluhm L, Grimmelmann I, Gutzmer R, Meier F, Garzarolli M, et al. Conference contribution Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB (TM)): 2-year results from the GABI-R-registry (2022) Pahmeier K, Neusser S, Hamm C, Kastner J, Wohrle J, Zahn R, Achenbach S, et al. Journal article SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TITAIN TRIAL (2022) Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Mendelson M, et al. Conference contribution Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic (2022) Voelk S, Pfirrmann M, Koedel U, Pfister HW, Lang T, Scheibe F, Salih F, et al. Journal article Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease (2022) Grueter T, Moellers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, et al. Journal article S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) (2022) Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, Mentzel T, et al. Journal article